Annual Total Expenses
$311.39 M
+$199.03 M+177.13%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total expenses is currently $311.39 million, with the most recent change of +$199.03 million (+177.13%) on 31 December 2023. During the last 3 years, it has risen by +$233.62 million (+300.40%). CPRX annual total expenses is now at all-time high.CPRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$77.79 M
+$9.32 M+13.62%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total expenses is currently $77.79 million, with the most recent change of +$9.32 million (+13.62%) on 30 September 2024. Over the past year, it has dropped by -$62.09 million (-44.39%). CPRX quarterly total expenses is now -44.39% below its all-time high of $139.88 million, reached on 30 September 2023.CPRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +177.1% | -44.4% |
| 3 y3 years | +300.4% | +254.4% |
| 5 y5 years | +769.9% | +356.2% |
CPRX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +300.4% | -44.4% | +254.4% |
| 5 y | 5 years | at high | +769.9% | -44.4% | +356.2% |
| alltime | all time | at high | >+9999.0% | -44.4% | >+9999.0% |
Catalyst Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $77.79 M(+13.6%) |
| June 2024 | - | $68.46 M(-4.1%) |
| Mar 2024 | - | $71.38 M(+3.6%) |
| Dec 2023 | $311.39 M(+177.1%) | $68.88 M(-50.8%) |
| Sept 2023 | - | $139.88 M(+164.5%) |
| June 2023 | - | $52.88 M(+6.3%) |
| Mar 2023 | - | $49.76 M(+66.1%) |
| Dec 2022 | $112.36 M(+27.0%) | $29.96 M(-6.8%) |
| Sept 2022 | - | $32.14 M(+31.0%) |
| June 2022 | - | $24.54 M(-4.6%) |
| Mar 2022 | - | $25.72 M(+0.6%) |
| Dec 2021 | $88.45 M(+13.7%) | $25.57 M(+16.5%) |
| Sept 2021 | - | $21.95 M(+6.9%) |
| June 2021 | - | $20.53 M(+0.6%) |
| Mar 2021 | - | $20.40 M(-8.9%) |
| Dec 2020 | $77.77 M(+10.3%) | $22.40 M(+27.2%) |
| Sept 2020 | - | $17.61 M(-8.8%) |
| June 2020 | - | $19.32 M(+4.8%) |
| Mar 2020 | - | $18.44 M(-16.6%) |
| Dec 2019 | $70.48 M(+96.9%) | $22.12 M(+29.7%) |
| Sept 2019 | - | $17.05 M(-4.6%) |
| June 2019 | - | $17.88 M(+33.1%) |
| Mar 2019 | - | $13.44 M(-12.4%) |
| Dec 2018 | $35.80 M(+91.6%) | $15.34 M(+87.5%) |
| Sept 2018 | - | $8.18 M(+29.1%) |
| June 2018 | - | $6.34 M(+6.8%) |
| Mar 2018 | - | $5.93 M(+7.6%) |
| Dec 2017 | $18.68 M(-3.1%) | $5.51 M(+28.0%) |
| Sept 2017 | - | $4.31 M(+3.0%) |
| June 2017 | - | $4.18 M(-10.7%) |
| Mar 2017 | - | $4.68 M(+8.5%) |
| Dec 2016 | $19.28 M(-5.5%) | $4.31 M(+10.2%) |
| Sept 2016 | - | $3.91 M(-18.7%) |
| June 2016 | - | $4.81 M(-22.8%) |
| Mar 2016 | - | $6.24 M(+0.7%) |
| Dec 2015 | $20.40 M | $6.19 M(+23.4%) |
| Sept 2015 | - | $5.02 M(+2.5%) |
| June 2015 | - | $4.90 M(+14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $4.29 M(+7.7%) |
| Dec 2014 | $14.59 M(+41.5%) | $3.98 M(-3.0%) |
| Sept 2014 | - | $4.11 M(+37.4%) |
| June 2014 | - | $2.99 M(-14.8%) |
| Mar 2014 | - | $3.51 M(+29.6%) |
| Dec 2013 | $10.31 M(+97.5%) | $2.71 M(-16.6%) |
| Sept 2013 | - | $3.25 M(+22.3%) |
| June 2013 | - | $2.65 M(+55.6%) |
| Mar 2013 | - | $1.71 M(+13.3%) |
| Dec 2012 | $5.22 M(-14.2%) | $1.51 M(+17.3%) |
| Sept 2012 | - | $1.28 M(+20.3%) |
| June 2012 | - | $1.07 M(-21.8%) |
| Mar 2012 | - | $1.36 M(-32.9%) |
| Dec 2011 | $6.08 M(+34.8%) | $2.03 M(+79.9%) |
| Sept 2011 | - | $1.13 M(-19.1%) |
| June 2011 | - | $1.40 M(-8.0%) |
| Mar 2011 | - | $1.52 M(+24.4%) |
| Dec 2010 | $4.51 M(-38.0%) | $1.22 M(+34.4%) |
| Sept 2010 | - | $908.50 K(-31.9%) |
| June 2010 | - | $1.33 M(+26.9%) |
| Mar 2010 | - | $1.05 M(-10.2%) |
| Dec 2009 | $7.28 M(-33.2%) | $1.17 M(-9.5%) |
| Sept 2009 | - | $1.29 M(-26.9%) |
| June 2009 | - | $1.77 M(-41.9%) |
| Mar 2009 | - | $3.04 M(-19.7%) |
| Dec 2008 | $10.89 M(+116.7%) | $3.79 M(+30.1%) |
| Sept 2008 | - | $2.91 M(+18.3%) |
| June 2008 | - | $2.46 M(+42.9%) |
| Mar 2008 | - | $1.72 M(+50.9%) |
| Dec 2007 | $5.03 M(+73.2%) | $1.14 M(+20.2%) |
| Sept 2007 | - | $950.40 K(-33.9%) |
| June 2007 | - | $1.44 M(-4.0%) |
| Mar 2007 | - | $1.50 M(+69.1%) |
| Dec 2006 | $2.90 M(+59.3%) | $885.20 K(-34.0%) |
| Sept 2006 | - | $1.34 M(+276.0%) |
| June 2006 | - | $357.00 K |
| Dec 2005 | $1.82 M(+235.6%) | - |
| Dec 2004 | $543.00 K(+112.2%) | - |
| Dec 2002 | $255.90 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual total expenses year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly total expenses year-on-year change?
What is Catalyst Pharmaceuticals annual total expenses?
The current annual total expenses of CPRX is $311.39 M
What is the all time high annual total expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total expenses is $311.39 M
What is Catalyst Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CPRX annual total expenses has changed by +$199.03 M (+177.13%)
What is Catalyst Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CPRX is $77.79 M
What is the all time high quarterly total expenses for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total expenses is $139.88 M
What is Catalyst Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CPRX quarterly total expenses has changed by -$62.09 M (-44.39%)